Loading
Everything OnCo dates to 1992: 36 entries, 15 landmarks, 8 journals founded, 4 papers listed on people's pages and 3 approvals. Each line links to the record it was read from, so the year is a view of the corpus rather than a second copy of it.
36 dated entries in OnCo fall in 1992: 15 landmarks, 8 journals founded, 4 papers listed on people's pages, 3 approvals, 2 laws and regulations, 2 papers, 1 company founded and 1 regulatory event.
Of those, 1 to the day and 35 to the year only. Most of the corpus dates a fact to the year, because that is what the source it was read from gives; regulatory events and the readout calendar are the parts that carry a full date.
Everything on this page is generated from the other records. It holds no fact of its own, and it changes when they do.
The approvals rows on treatment records: region, year and indication.
Metastatic renal cell carcinoma
Ovarian cancer (now broad)
Refractory childhood acute lymphoblastic leukaemia, in combination induction
The regulatory events on treatment records: designations, filings, decisions, label changes and withdrawals, most of them carrying a full date.
Refractory ovarian cancer
The statutes, regulations, guidance and court rulings in the law index, dated to the year the instrument was made.
United States, statute.
United States, regulation.
The publication year on key paper records.
Delattre O, Zucman J, Plougastel B, et al. Nature.
Klimstra DS, Heffess CS, Oertel JE, Rosai J. American Journal of Surgical Pathology.
The history entries editors wrote on cancer records: the dated turning points of each disease.
Perivascular epithelioid cell tumour (PEComa)
Mantle cell lymphoma. Mantle cell lymphoma recognised as a distinct entity (REAL classification 1994).
Esthesioneuroblastoma (olfactory neuroblastoma)
Hodgkin lymphoma
Ewing sarcoma
Renal cell carcinoma
Renal cell carcinoma
Melanoma. The first evidence that the immune system alone could eradicate metastatic melanoma.
Pancreatic acinar cell carcinoma
Limited-stage small-cell lung cancer
Small-cell lung cancer
Primary CNS lymphoma
Vaginal adenocarcinoma (including DES-associated clear cell adenocarcinoma)
Oesophageal squamous cell carcinoma
Breast cancer (all types). Nine candidate factors were tested in 387 patients and three survived: size, node stage and grade.
The founded year on company records.
New Haven, CT
The founded year on journal records.
Spandidos Publications
Springer Nature
Tech Science Press
Wiley
Association of Radiology and Oncology (Ljubljana), on the Sciendo platform
Elsevier
Elsevier
Elsevier
The selected publications each biography lists, which is a reading of that person rather than a reading of the year.
Nature
PNAS
Biometrics
Science